Onc Now | Episode 21
In this episode of Onc Now, host Jonathan Sackier is joined by Jean Abraham, Professor of Precision Breast Cancer Medicine at the University of Cambridge, to delve into the future of integrated cancer medicine, the evolving role of clinical trials, and how precision oncology is redefining outcomes for patients with breast cancer across the UK.
Apple | Spotify | Amazon Music (34 mins)
Jean Abraham is a Professor of Precision Breast Cancer Medicine at the University of Cambridge; and an Honorary Consultant in Medical Oncology at the University of Cambridge.
She directs the Precision Breast Cancer Institute, Cambridge, UK, and co-leads both the Integrated Cancer Medicine theme and the Breast Programme at the Cancer Research UK Cambridge Centre, UK. Her work focuses on translating cutting-edge discovery science into personalised treatments for patients, driving national clinical trials, and data-led innovation in breast cancer care.
Timestamps
- 00:00 – Introduction
- 01:28 – Quickfire round
- 09:50 – Cambridge institutes for precision medicine
- 12:53 – Predictive/prognostic tools in breast cancer
- 15:33 – The future of breast cancer clinical trials
- 18:34 – Integrating genomic data
- 22:31 – Addressing cost barriers
- 24:22 – How AI is transforming breast cancer care
- 28:08 – Why oncology?
- 30:04 – A message to non-oncologists
- 31:54 – Abraham’s three wishes for healthcare
